DR. COLE DAVIS

M.D.Real-Time Hydrated
Specialty: Urology
Practice Location: TULSA, OK 74146
NPI Number: 1205975224
LIFETIME INDUSTRY VALUE
$890
2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. DAVIS is a verified Urology practitioner based in TULSA, OK.

Between 2021 and 2024, Dr. DAVIS had an overall industry promotional and research financial footprint of $890 as recorded in the federal CMS Open Payments database.

  • $890 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. DAVIS's primary funding source is ASTELLAS PHARMA US, which accounts for $235 (representing 26.5% of overall industry footprint).

Data coverage: 2021 – 2024  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$266$133$0$2662021$2352022$2612023$1282024

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ASTELLAS PHARMA US
Rank 1
$235
26.5%
NOVARTIS PHARMACEUTICALS CORPORATION
Rank 2
$169
19%
BLUE EARTH DIAGNOSTICS LIMITED
Rank 3
$124
13.9%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2024
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.